• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Chemours Company

    6/10/25 4:00:13 PM ET
    $CC
    Major Chemicals
    Industrials
    Get the next $CC alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    The Chemours Company

    (Name of Issuer)


    Common Stock, par value $0.01 per share

    (Title of Class of Securities)


    163851108

    (CUSIP Number)


    06/03/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    163851108


    1Names of Reporting Persons

    Millennium Management LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    9,051,716.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    9,089,565.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    9,089,565.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    6.1 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    163851108


    1Names of Reporting Persons

    Millennium Group Management LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    9,051,716.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    9,089,565.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    9,089,565.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    6.1 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    163851108


    1Names of Reporting Persons

    Israel A. Englander
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    9,051,716.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    9,089,565.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    9,089,565.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    6.1 %
    12Type of Reporting Person (See Instructions)

    IN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    The Chemours Company
    (b)Address of issuer's principal executive offices:

    1007 Market Street, Wilmington, Delaware 19801
    Item 2. 
    (a)Name of person filing:

    Millennium Management LLC Millennium Group Management LLC Israel A. Englander
    (b)Address or principal business office or, if none, residence:

    Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
    (c)Citizenship:

    Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
    (d)Title of class of securities:

    Common Stock, par value $0.01 per share
    (e)CUSIP No.:

    163851108
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See response to Item 9 on each cover page.
    (b)Percent of class:

    See response to Item 11 on each cover page.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See response to Item 5 on each cover page.

     (ii) Shared power to vote or to direct the vote:

    See response to Item 6 on each cover page.

     (iii) Sole power to dispose or to direct the disposition of:

    See response to Item 7 on each cover page.

     (iv) Shared power to dispose or to direct the disposition of:

    See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.


    See Exhibit I
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Millennium Management LLC
     
    Signature:/s/ Gil Raviv
    Name/Title:Gil Raviv, Global General Counsel
    Date:06/09/2025
     
    Millennium Group Management LLC
     
    Signature:/s/ Gil Raviv
    Name/Title:Gil Raviv, Global General Counsel
    Date:06/09/2025
     
    Israel A. Englander
     
    Signature:/s/ Israel A. Englander
    Name/Title:Israel A. Englander
    Date:06/09/2025
    Exhibit Information

    Exhibit I: Joint Filing Agreement, dated as of June 9, 2025, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

    Get the next $CC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CC

    DatePrice TargetRatingAnalyst
    3/27/2025$19.00Neutral → Outperform
    Mizuho
    1/28/2025$27.00Buy
    Truist
    7/9/2024$28.00 → $30.00Neutral → Buy
    UBS
    6/7/2024$25.00Neutral
    Mizuho
    4/9/2024$19.00 → $34.00Underperform → Outperform
    BMO Capital Markets
    3/5/2024$37.00 → $21.00Buy → Neutral
    UBS
    2/29/2024$45.00 → $19.00Outperform → Underperform
    BMO Capital Markets
    12/1/2023$28.00 → $40.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $CC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Gumpel Damian bought $201,376 worth of shares (21,222 units at $9.49), increasing direct ownership by 19% to 131,701 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      6/4/25 8:32:18 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chief Financial Officer Hostetter Shane bought $50,196 worth of shares (4,450 units at $11.28), increasing direct ownership by 8% to 59,694 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      5/21/25 5:13:57 PM ET
      $CC
      Major Chemicals
      Industrials
    • Director Cowan Alister was granted 14,096 shares, increasing direct ownership by 65% to 35,831 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      4/24/25 5:36:51 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Chemours Appoints Matthew Conti as Chief Human Resources Officer

      Seasoned HR executive supports Chemours' Pathway to Thrive strategy The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612880421/en/Chemours appoints Matthew Conti as Chief Human Resource

      6/12/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

      The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company, announced the appointment of Nathan Blom as Vice President of its liquid cooling portfolio, effective June 9, 2025. With Blom's wealth of technology and data center experience, his addition reinforces Chemours' commitment to driving near- and long-term growth in the liquid cooling market. Bringing over two decades of experience in executive leadership, business transformation, and go-to-market strategy across the technology and data center infrastructure sectors, Blom is a strong addition to Chemours leadership. The appointment supports the company's "Pathway to Thrive" strategy, with liquid cooling representing a ke

      6/10/25 6:45:00 AM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours and DataVolt Announce Agreement to Accelerate Adoption of Liquid Cooling Solutions & Support Broader Innovation for Future-Ready AI Data Centers

      Collaboration to Focus on Increasing Data Center Efficiency & Sustainability The Chemours Company (Chemours) (NYSE:CC), a global chemistry company, announced a strategic agreement with DataVolt, a designer, developer, and operator of sustainable digital infrastructure, to further demonstrate and develop advanced liquid cooling solutions for data centers alongside other industry leaders. This collaboration will focus on increasing data center efficiency and sustainability through two-phase direct-to-chip, two-phase immersion cooling, and other innovative solutions. The companies will work to enhance infrastructure readiness and address the increasing demands of artificial intelligence (AI)

      5/19/25 6:30:00 AM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Gumpel Damian bought $201,376 worth of shares (21,222 units at $9.49), increasing direct ownership by 19% to 131,701 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      6/4/25 8:32:18 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chief Financial Officer Hostetter Shane bought $50,196 worth of shares (4,450 units at $11.28), increasing direct ownership by 8% to 59,694 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      5/21/25 5:13:57 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Chemours upgraded by Mizuho with a new price target

      Mizuho upgraded Chemours from Neutral to Outperform and set a new price target of $19.00

      3/27/25 8:05:02 AM ET
      $CC
      Major Chemicals
      Industrials
    • Truist initiated coverage on Chemours with a new price target

      Truist initiated coverage of Chemours with a rating of Buy and set a new price target of $27.00

      1/28/25 7:09:50 AM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours upgraded by UBS with a new price target

      UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously

      7/9/24 8:13:51 AM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Leadership Updates

    Live Leadership Updates

    See more
    • Chemours Appoints Matthew Conti as Chief Human Resources Officer

      Seasoned HR executive supports Chemours' Pathway to Thrive strategy The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612880421/en/Chemours appoints Matthew Conti as Chief Human Resource

      6/12/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

      The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company, announced the appointment of Nathan Blom as Vice President of its liquid cooling portfolio, effective June 9, 2025. With Blom's wealth of technology and data center experience, his addition reinforces Chemours' commitment to driving near- and long-term growth in the liquid cooling market. Bringing over two decades of experience in executive leadership, business transformation, and go-to-market strategy across the technology and data center infrastructure sectors, Blom is a strong addition to Chemours leadership. The appointment supports the company's "Pathway to Thrive" strategy, with liquid cooling representing a ke

      6/10/25 6:45:00 AM ET
      $CC
      Major Chemicals
      Industrials
    • DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

      3/7/25 6:19:00 PM ET
      $ALK
      $AMBC
      $ATI
      $BBWI
      Air Freight/Delivery Services
      Consumer Discretionary
      Property-Casualty Insurers
      Finance

    $CC
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Chemours Company

      SCHEDULE 13G - Chemours Co (0001627223) (Subject)

      6/10/25 4:00:13 PM ET
      $CC
      Major Chemicals
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Chemours Company

      SCHEDULE 13G/A - Chemours Co (0001627223) (Subject)

      6/6/25 10:03:48 AM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form SD filed by Chemours Company

      SD - Chemours Co (0001627223) (Filer)

      5/29/25 4:35:48 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Chemours Company

      SC 13G/A - Chemours Co (0001627223) (Subject)

      11/12/24 9:55:16 AM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Chemours Company (Amendment)

      SC 13G/A - Chemours Co (0001627223) (Subject)

      2/9/24 8:50:19 AM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Chemours Company (Amendment)

      SC 13G/A - Chemours Co (0001627223) (Subject)

      1/24/24 9:46:44 AM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Financials

    Live finance-specific insights

    See more
    • Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call

      The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2025 financial results after market on Tuesday, May 6, 2025. The Company expects to hold its conference call to discuss its first quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, May 7, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC) is a glo

      4/16/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Announces First Quarter Dividend

      The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the first quarter of 2025. The dividend will be paid on March 14, 2025, to stockholders of record as of the close of business on February 28, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solut

      2/14/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Announces Dates for Fourth Quarter 2024 Earnings Release and Webcast Conference Call

      The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its fourth quarter 2024 financial results before market on Tuesday, February 18, 2025. The Company expects to hold its conference call to discuss its fourth quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Tuesday, February 18, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (

      2/3/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials